Innovating a sustainable future through PHACT™ PHA
About CJ Biomaterials
Built on Biotech Innovation
CJ Biomaterials was established in 2022 - building on a decades-long history in food and biotechnology.
The base of the technology for our PHACT™ PHA platform dates back to 2010, when the CJ Group first stepped into biotechnology. Then in 2016, CJ CheilJedang, a subsidiary of CJ Group, acquired Metabolix and its PHA (polyhydroxyalkanoate) technology. The combination of the two platforms has created the company we are today.
Our Foundation
Built for Scale
From advanced biotechnology to global manufacturing, CJ Biomaterials combines deep expertise, innovation, and infrastructure to deliver scalable PHA solutions across industries.
Advanced PHA technology, built for real-world scale
CJ Biomaterials has the core technology platforms necessary to implement PHA-based solutions at scale, including bioscience, chemical engineering, materials innovation and applications development. We have the technology, expertise, and production capacity to make an impact with PHA in global markets and variety of applications – ranging from flexible and rigid packaging, food serviceware, 3D printing and agricultural films to coatings, and personal care.
Backed by a global leader in biotechnology and manufacturing
CJ Biomaterials is supported in our activities by our parent organizations – the CJ Group, CJ CheilJedang and its CJ BIO division. CJ Group is a South Korean conglomerate holding company headquartered in Seoul. It includes numerous businesses in food and food service industries, pharmaceutics and biotechnology, entertainment and media, beauty, home shopping and logistics.
Decades of expertise driving continuous innovation
CJ CheilJedang, which is a subsidiary of CJ Group, is a South Korean food and biotechnology company based in Seoul that manufactures food ingredients, ambient, frozen and chilled packaged food products, pharmaceuticals and biotechnology. CJ CheilJedang launched its BIO division and started its biotechnology business in 1964 with the production of monosodium glutamate. With 13 global manufacturing facilities, CJ BIO is the world's leading supplier of fermentation-based bio products for animal nutrition, human nutrition, and biomaterials.
Our Impact
Creating Materials That Move Industries Beyond Traditional Plastics
CJ Biomaterials develops meaningful solutions that positively affect our planet and human health and well-being by addressing the challenges posed by fossil fuel-based technologies – including plastic waste. CJ Biomaterials invents and manufactures bio-based chemicals and biopolymers as part of a long-term vision to create a more sustainable future by offering circular solutions that replace many non-recyclable, non-reusable and fossil fuel-based plastics and chemicals.
“We create sustainable values to save lives and protect the earth”
CJ Biomaterials Mission Statement
Our Journey
From Innovation to Global Production
CJ Biomaterials' journey spans over a decade of biotechnology innovation, strategic acquisitions, and large-scale production, culminating in the launch of certified PHA solutions.
-
2010
Biotechnology Foundations
CJ Group establishes its core biomaterials technology platforms, marking its entry into biotechnology and laying the foundation for future PHA development.
-
2016
Metabolix Acquisition
CJ acquires Metabolix and its PHA technology, expanding its capabilities in biopolymers and enabling scalable production to meet industry demand.
-
2020 2021
Indonesia Plant Construction
CJ begins construction of its PHA production facility in Pasuruan, Indonesia, designed to support large-scale manufacturing (5,000 tons/year).
-
2022
Launch & Commercialization
CJ Biomaterials is officially launched, the Indonesia plant becomes operational, and the company introduces its first product, PHACT™ A1000P, a certified biodegradable material suitable for industrial compost, soil, and marine environments.
Ready to learn more about how PHACT™ PHA can be used in your products?
FAQs
Frequently Asked Questions
Find answers to common questions about PHA materials, applications, performance, and sustainability.
Explore PHA for Your Application
Our technical team can help evaluate materials, performance requirements, and sustainability targets for your product.
CJ Biomaterials is the biomaterials division of CJ CheilJedang, producing PHACT branded PHA biopolymers at commercial scale.
CJ Biomaterials produces PHA biopolymers and related basic chemicals using fermentation based biotechnology. Building on decades of experience in food and biotechnology, the company uses bioscience, chemical engineering, materials innovation, and applications development to manufacture PHA solutions at scale for global markets.
Packaging, food serviceware, agriculture, personal care and consumer goods are the most common, wherever a persistent plastic can be replaced.
PHA breaks down in soil, industrial compost and marine environments, so it does not persist as microplastic at end of life.
They shorten the time a discarded product remains in the environment, which reduces accumulation in landfill and waterways.